Medical Devices News and Research

RSS

Recent developments at Burnham Institute for Medical Research

New antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) and other pesky bacteria. Andrei Osterman and collaborators have used comparisons of bacterial genomes to identify new targets for antibiotics and produced first-generation chemical inhibitors of a class of bacterial enzymes, called NadDs (nicotinate mononucleotide adenylyltransferases).

17 Nov 2009

China Medicine reports total revenues of $19.2M for the third quarter of 2009

China Medicine Corporation, a developer and a leading distributor of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, and medical devices and medical formulations, today announced its third quarter 2009 results.

16 Nov 2009

Windhover Information selects Oncothyreon's PX-866 among top 10 oncology projects for partnering

Oncothyreon Inc. today announced that the Company's product candidate PX-866, a PI-3 kinase inhibitor, has been selected by Windhover Information, Inc., as one of the Top 10 most promising oncology projects in development that is available for partnering.

16 Nov 2009

ART Advanced Research Technologies receives delisting notice from TSX

ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announced that it will delay the release of its financial results for the third quarter ended September 30, 2009, considering the restructuring process that the company is currently undergoing.

16 Nov 2009

Cappella commences evaluation of the Sideguard Coronary Sidebranch Stent & Delivery System

Cappella, Inc., a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the start of Sideguard 3, an IVUS/OCT evaluation of the Sideguard® Coronary Sidebranch Stent & Delivery System. This is a European multicenter study to evaluate the vascular response to Sideguard in de novo bifurcation lesions of native coronary arteries.

16 Nov 2009

Misonix inks a three-year distribution agreement with Xenith in Dubai

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Xenith, LLC, based in Dubai, UAE, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator, the BoneScalpel(TM) Ultrasonic Bone Cutter, and the SonicOne® Ultrasonic Wound Debrider.

13 Nov 2009

Amorfix Life Sciences reports operating results for the three months ended September 30, 2009

Amorfix Life Sciences, a company focused on misfolded protein diseases, today reported its second quarter operating results and provided an update on the Company's diagnostic and therapeutic programs.

13 Nov 2009

Report offers strategic marketing resources to support product portfolios in medical device sector

Like all industries, the medical device sector is constantly seeking to align its marketing staffing levels to optimal organizational performance. A recent study by Best Practices, LLC found that strategic marketers in the medical device sector typically support about 10 products per marketer, indicating portfolio prioritization is essential to success.

13 Nov 2009

BSI implements plans to expand its medical device Notified Body scope to include IVD devices

BSI, a world-class Notified Body providing regulatory and quality management reviews and product certification for medical devices, is rapidly implementing plans to expand its medical device Notified Body scope to include in vitro diagnostic (IVD) devices.

13 Nov 2009

Second-quarter fiscal 2010 results announced by AdvanSource Biomaterials

AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced financial results for its fiscal 2010 second quarter ended September 30, 2009.

12 Nov 2009

Detailed review findings of EMPOWER study to evaluate the Maestro System released

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, today announced preliminary findings from its ongoing detailed review of its EMPOWER™ study, a randomized, double-blind, controlled pivotal study designed to evaluate the safety and efficacy of the Maestro® System in the treatment of obesity.

12 Nov 2009

Jonathan Richman to present at FDA public hearing on promoting medical devices using the Internet

Bridge Worldwide announced today that Jonathan Richman, Director of Strategic Planning, will present at the public hearing on "Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools," to be held on November 12 and 13, 2009, from 8 a.m. to 5 p.m., at the National Transportation Safety Board Conference Center in Washington, D.C. Richman is scheduled to speak on Friday, November 13, at 11:40 a.m. and 2:40 p.m. for 10 minutes per time slot. To listen to a free, live webcast of the hearing, go to: www.capitolconnection.net/capcon/fda/111209/FDAlive.htm.

12 Nov 2009

PaLFI device: An innovative way to remotely communicate and power implantable medical devices

Developers in medical, industrial and consumer applications continuously strive to increase wireless functionality to enhance the convenience of products. Texas Instruments today announced the first member of a new product class featuring the industry's first passive low frequency interface (PaLFI) device designed to wirelessly supply an ultra-low-power MSP430 microcontroller (MCU) with energy to operate even if the optional battery is empty.

12 Nov 2009

Nicast to launch the NovaMesh intra-abdominal hernia mesh in Europe

Nicast, developer of medical devices made of electrospun nanofabric, announced today it is readying to launch the NovaMesh intra-abdominal hernia mesh in the European market in Q1 2010, pending European regulatory approval. NovaMesh is the first intra-abdominal hernia mesh to utilize the special properties of electrospun nanofabric.

12 Nov 2009

New research center established to improve cardiac safety

The University of Rochester Medical Center has announced the creation of a new center that will assist researchers studying the electrical activity of the heart with the goal of improving drug safety, understanding cardiac arrhythmias, and developing new electrocardiograph technologies.

12 Nov 2009

Positive results from Puricore's Vashe Wound Therapy efficacy trial

PuriCore, the life sciences company focused on developing and commercializing proprietary solutions that safely, effectively, and naturally kill infectious pathogens, today announced results of a randomized clinical trial showing the potential effectiveness of its Vashe Wound Therapy in the post-operative care of split-thickness skin grafts for burn injuries.

11 Nov 2009

Ocutec receives CE Mark approval for its first PEG hydrogel-based contact lens product

Ocutec Ltd, the medical devices specialist today announced at the American Academy of Optometry Meeting in Orlando CE Mark approval for its first poly(ethylene )glycol (PEG) hydrogel-based contact lens product. In initial patient acceptance trials, this next generation of lenses has demonstrated superior oxygen permeability compared to existing hydrogel based lenses.

11 Nov 2009

Biopharma leaders to discuss optimized clinical operations and outsourcing strategies at iiBIG's forum

iiBIG and the newly formed Global Biopharmaceutical Advisory Board have jointly planned an event that will focus on one of the most dynamic trends in the pharmaceutical, biotechnology, and medical device industries -- strategic outsourcing. Biopharma CEOs, VPs of Global Operations, and Department Heads will meet at the 4th Annual Global Clinical Trial Partnerships, March 1-2, 2010, in Princeton, New Jersey to discuss the latest strategies for optimizing global operations.

11 Nov 2009

Premier healthcare alliance expert's efforts to enhance patient safety receives recognition from DoD

The United States Department of Defense (DoD) has recognized a Premier healthcare alliance expert for his efforts to enhance patient safety while reducing healthcare costs.

11 Nov 2009

Lerner Medical Devices selects QuantumMethod for branding and launching its Levia phototherapy device

QuantumMethod announced today that Lerner Medical Devices, Inc. has selected the firm as agency of record, tasked with branding and launching Levia®, the company's new Personal Targeted Phototherapy™ device for the self-treatment of psoriasis. Levia® enables their patients to target their small area and scalp psoriasis with therapeutic ultraviolet light via proprietary delivery systems designed for precise, fast and safe treatment.

11 Nov 2009

Medical Devices News and Research

Recent developments at Burnham Institute for Medical Research

China Medicine reports total revenues of $19.2M for the third quarter of 2009

Windhover Information selects Oncothyreon's PX-866 among top 10 oncology projects for partnering

ART Advanced Research Technologies receives delisting notice from TSX

Cappella commences evaluation of the Sideguard Coronary Sidebranch Stent & Delivery System

Misonix inks a three-year distribution agreement with Xenith in Dubai

Amorfix Life Sciences reports operating results for the three months ended September 30, 2009

Report offers strategic marketing resources to support product portfolios in medical device sector

BSI implements plans to expand its medical device Notified Body scope to include IVD devices

Second-quarter fiscal 2010 results announced by AdvanSource Biomaterials

Detailed review findings of EMPOWER study to evaluate the Maestro System released

Jonathan Richman to present at FDA public hearing on promoting medical devices using the Internet

PaLFI device: An innovative way to remotely communicate and power implantable medical devices

Nicast to launch the NovaMesh intra-abdominal hernia mesh in Europe

New research center established to improve cardiac safety

Positive results from Puricore's Vashe Wound Therapy efficacy trial

Ocutec receives CE Mark approval for its first PEG hydrogel-based contact lens product

Biopharma leaders to discuss optimized clinical operations and outsourcing strategies at iiBIG's forum

Premier healthcare alliance expert's efforts to enhance patient safety receives recognition from DoD

Lerner Medical Devices selects QuantumMethod for branding and launching its Levia phototherapy device

Industry Focus - Medical Device eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News